Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 59 checked references that resolve
resolves10.1007/s00262-015-1761-xNK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
resolves10.1007/s12185-019-02616-yImpact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia
resolves10.1158/1078-0432.CCR-16-1904Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia
resolves10.1089/hum.2018.247Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies
resolves10.3389/fimmu.2017.00533Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
resolves10.1080/14653240802301872Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
resolves10.1016/j.freeradbiomed.2012.04.033Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint
resolves10.3390/ijms17010102Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization
resolves10.1128/AEM.00081-11Inactivation of a Human Norovirus Surrogate, Human Norovirus Virus-Like Particles, and Vesicular Stomatitis Virus by Gamma Irradiation
resolves10.3389/fimmu.2017.00613Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
resolves10.1038/s41598-020-69347-7Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
resolves10.1016/j.radphyschem.2018.04.008Low-energy electron-beam treatment as alternative for on-site sterilization of highly functionalized medical products – A feasibility study
resolves10.3390/v8110319Pathogens Inactivated by Low-Energy-Electron Irradiation Maintain Antigenic Properties and Induce Protective Immune Responses
resolves10.1007/s00109-015-1327-6Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
resolves10.1088/1742-6596/151/1/012022Quartz-Containing Ceramic Dusts:<i>In vitro</i>screening of the cytotoxic, genotoxic and pro-inflammatory potential of 5 factory samples
resolves10.1039/C5MB00663EReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization
resolves10.1089/omi.2011.0118clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
resolves10.1038/ncomms12171Human NK cell development requires CD56-mediated motility and formation of the developmental synapse
resolves10.3389/fimmu.2018.00283Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
resolves10.1007/s00262-017-2055-2Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
resolves10.1038/mt.2014.219Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
resolves10.1089/10430349950018030Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy
resolves10.18632/oncotarget.13411An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
resolves10.1016/j.jcyt.2020.06.003Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse model
resolves10.3390/cells9061382Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
resolves10.1016/j.molonc.2013.12.001Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
resolves10.3324/haematol.2017.187385CD16<sup>+</sup>NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice
resolves10.1089/106161299320316Immunotherapy of Malignant Melanoma in a SCID Mouse Model Using the Highly Cytotoxic Natural Killer Cell Line NK-92
resolves10.18632/oncotarget.19204A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
resolves10.3389/fonc.2013.00118Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
resolves10.1002/ijc.30767ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody
resolves10.1210/en.2014-1709GnRH Regulates Gonadotropin Gene Expression Through NADPH/Dual Oxidase-Derived Reactive Oxygen Species
resolves10.1038/leu.2013.279CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
resolves10.1038/srep11483CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
resolves10.1155/2017/6915912Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
resolves10.1155/2018/4263520Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
resolves10.1007/s00262-015-1669-5Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.